MXCT

MaxCyte
MXCT

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
£228.57M
EV
£119.58M
Shares Outstanding
106.31M
Beta
1.21

Wall Street View

Analyst Rating
BUY
Analyst Target Price
£6.49
P/E 2025E
-
P/Revenue 2025E
7.40x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About MaxCyte, Inc.

gainify
MXCT

MaxCyte, Inc.

MXCT

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT...

Sector

Healthcare

Industry

Medical - Devices

CEO

Masoud, Maher

Employees

114

IPO Date

2016-03-29

Headquarters

9713 Key West Avenue, Suite 400, Rockville, Maryland, 20850, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved